Pancreatitis - Microbiome as Predictor of Severity II
University Medical Center Goettingen
700 participants
May 1, 2024
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to evaluate the orointestinal microbiome and microbial derived metabolome in patients suffering from acute pancreatitis as a biomarker for severity. The main questions it aims to answer are: * Can the orointestinal microbiome robustly predict the course of acute pancreatitis? * How does the microbiome impact the severity of an acute pancreatitis? Buccal/ rectal swabs, plasma and stool is collected from patients with acute pancreatitis within 48h after hospital admission.
Eligibility
Inclusion Criteria3
- Patients with initial diagnosis (\< 48h) of acute pancreatitis
- Age ≥ 18 years
- Patients able to understand/ give their written consent
Exclusion Criteria3
- Recurrent acute pancreatitis (\>2 previous episodes)
- Clinical or imaging signs of chronic pancreatitis
- Referred patients with length of hospital stay \> 48h
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06508502